Category: Cancer

Cancer

DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging

Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.

EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study
Home HPV Self-Sampling Kits Show Promise for Closing Cervical Screening Gap in Disabled Women
Urine-Based Liquid Biopsy Shows High Sensitivity for Prostate Cancer Detection
New Whole Genome and Transcriptome Assay Launches for Myeloid Malignancies
Blood Test Using Inflammatory Biomarkers Advances for Colorectal Cancer Detection
Molecular Test Detects Bile Duct Cancer at Twice the Rate of Standard Methods
New AI Test Estimates Individualized Chemotherapy Benefit in Breast Cancer Patients
Lunit, CellCarta Partner to Advance AI-Powered Digital Pathology for Companion Diagnostics
Nucleosome Levels Found Elevated in Trauma Patients at Risk for Blood Clots, Mayo Clinic Study Shows

Cancer

DPYD Testing Gaps Leave Colorectal Cancer Patients at Risk for Severe Drug Toxicity

Inherited variants in the DPYD gene can increase the risk of life-threatening toxicity from fluoropyrimidine-based chemotherapies, yet screening remains inconsistent across care settings.

Cancer

Primerdesign and Origin Sciences Partner to Optimize DNA Extraction from Rectal Mucus for Colorectal Cancer Detection

The collaboration has produced a custom nucleic acid extraction workflow designed to unlock molecular insights from a novel biospecimen and improve diagnostic utility in gut health conditions.

Protein Biomarker Tests May Detect Cancer Earlier Than DNA-Based Methods

Mar 12, 2026 | Cancer

20/20 BioLabs argues a tiered screening approach—starting with protein-based tests before moving to circulating tumor DNA testing or imaging—could improve early-stage detection and lower costs.

Study Finds Multi-Omic Breast Cancer Test Predicts Radiation Therapy Benefit

Mar 12, 2026 | Breast

Data show the test can predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer.

Guardant’s Shield CRC Blood Test Now Orderable Through Quest Diagnostics Network

Mar 11, 2026 | Colorectal

Physicians can now order the Shield blood test through Quest’s network of nearly 650,000 clinician and hospital accounts, patient service centers, and in-office phlebotomists.

Study Shows Dual Epigenetic Markers Improve Early Colorectal Cancer Detection

Mar 9, 2026 | Colorectal

A study reports that dual epigenetic markers in cell-free DNA achieved 95% diagnostic accuracy for stage I colorectal cancer, outperforming conventional liquid biopsy methods.

FDA Grants Breakthrough Status to Breath Test for Postoperative Pneumonia Risk

Feb 27, 2026 | Cancer, Cardiovascular, Diagnostic Technologies, Mass Spectrometry

The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.’s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.

Fecal DNA Methylation Test Shows Promise for Colorectal Cancer Screening

Feb 27, 2026 | Colorectal

A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.

Blood Test Could Enable Earlier Detection of Gallbladder Cancer

Feb 27, 2026 | Cancer

Researchers have identified blood-based metabolic signatures that may enable earlier, noninvasive detection of gallbladder cancer, according to findings in the Journal of Proteome Research.

Veracyte Presents 15 Studies on Decipher Cancer Tests at ASCO GU Symposium

Feb 26, 2026 | Prostate

Veracyte will present over 15 studies on its Decipher prostate and bladder cancer tests, including new clinical trial data, at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.

NeoGenomics Launches PanTracer Pro for Solid Tumor Testing

Feb 26, 2026 | Cancer, Diagnostic Technologies, Molecular Diagnostics

The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.

Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses

Feb 24, 2026 | Cancer, Diagnostic Technologies, Molecular Diagnostics

The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.

ClearNote Health Launches Enhanced Pancreatic Cancer Blood Test

Feb 23, 2026 | Pancreatic

ClearNote Health has launched an enhanced pancreatic cancer test, reporting 82.6% sensitivity and 97.5% specificity in high-risk patients using a multianalyte, multiomic blood-based approach.

Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance

Feb 18, 2026 | Lung Cancer

The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.

Guardant Health Offers Free Colorectal Cancer Screening Tests Through Community Grant Program

Feb 18, 2026 | Colorectal

Guardant Health will provide up to 100 free Shield blood tests per organization to support colorectal cancer screening events and outreach during Colorectal Cancer Awareness Month in March.

First Ascent Biomedical Opens Cancer Testing Lab in Miami

Feb 17, 2026 | Cancer

The CLIA-certified facility offers functional precision medicine testing that analyzes live tumor cells against FDA-approved therapies within 10 days.

Hims & Hers Adds Multi-Cancer Blood Test to Digital Health Platform

Feb 9, 2026 | Cancer

Hims & Hers Health is now offering GRAIL’s Galleri multi-cancer blood test through its digital health platform, expanding access to screening for more than 50 cancer types, including those lacking established protocols.